In situ comparison of 665 nm and 633 nm wavelength light penetration in the human prostate gland.
AffiliationDepartment of Experimental Radiation Oncology, Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Manchester, UK.
MetadataShow full item record
AbstractThe depth of treatment in photodynamic therapy (PDT) of tumors varies with the wavelength of light activating the photosensitizer. New generation photosensitizers that are excited at longer wavelengths have the potential for increasing treatment depths. Tin ethyl etiopurpurin (SnET2), a promising second-generation photosensitizer is maximally activated at 665 nm, which may be significantly more penetrating than 633 nm light currently used with porphyrins in PDT. The penetration of 665 nm and 633 nm wavelength red light in the prostate gland was compared in 11 patients undergoing prostatic biopsies for suspected prostatic cancer. Interstitial optical fibers determined the light attenuation within the prostate gland. Of the 11 patients, 7 had dual wavelength and 4 had single wavelength studies. The mean attenuation coefficients, mueff, for 665 nm and 633 nm wavelength light were 0.32 +/- 0.05 mm-1 and 0.39 +/- 0.05 mm-1, respectively, showing a statistically significant difference (P = 0.0003). This represented a 22% increase in the mean penetration depth and at 10 mm from the delivery fiber there was 1.8 times as much 665 nm light fluence than 633 nm. The mean mueff at 665 nm for benign and malignant prostate tissue were similar (P = 0.42), however, there was significant interpatient variation (mueff ranging from 0.24 to 0.42 mm-1) reflecting biological differences of therapeutic importance. The enhanced light fluence and penetration depth with 665 nm light should allow significantly larger volumes of prostatic tissue to be treated with SnET2-mediated PDT.
CitationIn situ comparison of 665 nm and 633 nm wavelength light penetration in the human prostate gland. 1995, 62 (5):882-6 Photochem. Photobiol.
JournalPhotochemistry and Photobiology
- Spatial distribution of liposome encapsulated tin etiopurpurin dichloride (SnET2) in the canine prostate: implications for computer simulation of photodynamic therapy.
- Authors: Aniola J, Selman SH, Lilge L, Keck R, Jankun J
- Issue date: 2003 Mar
- In vivo laser light distribution in human prostatic carcinoma.
- Authors: Whitehurst C, Pantelides ML, Moore JV, Brooman PJ, Blacklock NJ
- Issue date: 1994 May
- Transperineal in vivo fluence-rate dosimetry in the canine prostate during SnET2-mediated PDT.
- Authors: Lilge L, Pomerleau-Dalcourt N, Douplik A, Selman SH, Keck RW, Szkudlarek M, Pestka M, Jankun J
- Issue date: 2004 Jul 21
- Optical characteristics of the canine prostate at 665 nm sensitized with tin etiopurpurin dichloride: need for real-time monitoring of photodynamic therapy.
- Authors: Jankun J, Lilge L, Douplik A, Keck RW, Pestka M, Szkudlarek M, Stevens PJ, Lee RJ, Selman SH
- Issue date: 2004 Aug
- Studies of tin ethyl etiopurpurin photodynamic therapy of the canine prostate.
- Authors: Selman SH, Albrecht D, Keck RW, Brennan P, Kondo S
- Issue date: 2001 May